Navigation Links
Avisena Closes $2.5 Million of Debt Capital By Square 1 Bank
Date:7/11/2011

MIAMI, July 11, 2011 /PRNewswire/ -- Avisena, one of the nation's leading providers of revenue cycle management software and services for physician practices, today announced the extension of a $2.5 million debt facility from Square 1 Bank. The facility will be used to accelerate the Company's strategic expansion into new markets through additional investments in sales and marketing.

"Square 1 believes in supporting high growth businesses with great leadership and satisfied customers. We are proud to partner with Avisena and provide additional resources to support their growing customer base," said Peter Meath, Senior Vice President of Square 1 Bank.

"Our core mission is to improve the financial condition of our physician partners while making healthcare transactions easier on patients, physicians, billing staff, payers and Avisena employees," said Joseph Radigan, CEO of Avisena. "We are delighted that Square 1 shares our vision and will provide additional resources so we can continue to provide exceptional service and new capabilities to our provider clients."

About Avisena:

Avisena is a revenue-cycle management company that provides fully-integrated software and comprehensive support services to help physician practices increase collections, reduce costs, and improve operating efficiency. Based in Miami, the Company delivers on-demand insight into practice productivity and results that optimize workflow and improve financial performance.  For more information, call 877-889-4117 or visit www.avisena.com.

About Square 1 Bank:

Square 1 Bank is a full service commercial bank dedicated exclusively to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion. Square 1's expertise, focus and strong capital base provide solid support for its clients' needs. The bank offers tailored products and solutions aided by the latest in technological innovations. To serve its relationships, Square 1 has offices coast to coast in Austin, Boston, Boulder, Durham, McLean, New York, San Diego, Santa Monica, Seattle, and Silicon Valley. For more information, visit www.square1bank.com.


'/>"/>
SOURCE Avisena
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL Closes the Acquisition of ClinPhone
2. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
3. Pathwork Diagnostics Closes $20M Financing
4. World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round
5. AMDL, Inc. Closes Private Placement of Convertible Notes
6. ForteBio, Inc. Closes $25 Million In Series C Financing
7. Helix Biopharma Closes $11.4 Million Private Placement
8. Micromet Closes $40 Million Private Equity Placement
9. Great Basin Scientific, Inc. Closes $3.9 Million in Equity Funding
10. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
11. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):